单位(元)工银医药健康股票C(006003)利润表 |
报告期 |
2022/6/30 |
2021/12/31 |
2021/6/30 |
2020/12/31 |
收入 |
-419,380,047 |
89,854,992 |
629,164,237 |
951,499,002 |
利息收入 |
996,963 |
2,620,994 |
887,640 |
1,098,670 |
其中:存款利息收入 |
923,138 |
1,316,644 |
555,472 |
947,036 |
债券利息收入 |
- |
1,377 |
753 |
4,254 |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
73,825 |
1,302,973 |
331,415 |
147,381 |
投资收益 |
-114,970,384 |
272,415,269 |
319,088,998 |
419,079,615 |
其中:股票投资收益 |
-129,229,665 |
263,558,551 |
313,105,311 |
401,587,727 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
1,046,199 |
1,616,187 |
387,871 |
11,541,562 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
13,213,082 |
7,240,531 |
5,595,816 |
5,950,326 |
公允价值变动收益 |
-307,600,024 |
-193,876,385 |
304,615,070 |
518,305,332 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
2,193,398 |
8,695,114 |
4,572,530 |
13,015,385 |
费用 |
31,062,378 |
64,656,722 |
27,388,029 |
40,888,489 |
管理人报酬 |
24,113,102 |
43,815,716 |
19,475,750 |
25,611,228 |
托管费 |
4,018,850 |
7,302,619 |
3,245,958 |
4,268,538 |
销售服务费 |
2,768,429 |
4,062,494 |
1,746,077 |
3,659,233 |
交易费用 |
- |
9,181,267 |
2,773,624 |
7,065,832 |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
161,995 |
294,621 |
146,617 |
283,642 |
利润总额 |
-450,442,425 |
25,198,270 |
601,776,208 |
910,610,513 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
-450,442,425 |
25,198,270 |
601,776,208 |
910,610,513 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。